Optolane
PrivateLast Round
Series D
Extension
Nov 1, 2024
Est. Valuation
$35.86M
Total Funding Raised
$71.92M
Company Overview
Optolane operates in Healthcare & Life Sciences and is based in Yongin-si. Its latest recorded funding round was a Series D Extension round in November 2024.
Optolane is a biotechnology company that develops semiconductor-based molecular diagnostic platforms and digital PCR systems for healthcare and research applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine, Semiconductors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Optolane Comparables
Compare Optolane with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| miDiagnostics | 82% | |
| Shanghai Turtle Technology Co., Ltd. | 79% | |
| TargetingOne Corporation | 77% |
For institutional investors. Book with your work email.
Optolane Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D Extension | Nov 1, 2024 | ||||
| Series D | Jul 1, 2023 | ||||
| Series C | Jun 1, 2021 | ||||
| Series C | Dec 1, 2019 | ||||
| Series B Extension | Aug 31, 2018 | ||||
Series B | Aug 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Optolane Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series B Extension |
| BNH INVESTMENT | Series B |
| UTC Investment | Series C |
| Timefolio Asset Management | Series B Extension |
| Wonik Investment Partners | Series B, Series A |
| L&S Venture Capital | Series B Extension, Series B, Series D |
| LSK Investment | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2025
Attended the EUDIP2025 event in Ghent, Belgium on July 1, 2025.
- Nov 1, 2024
Raised $9.4M in a Series D Extension round.
For institutional investors. Book with your work email.
Optolane Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Optolane's valuation, stock price, and market status.
Is Optolane a public or private company?
Optolane is a private company.
What is the current stock price of Optolane?
Optolane is a private company, so its shares have no public market price. Caplight tracks Optolane's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Optolane worth (valuation)?
Optolane's valuation is estimated at $35.9M based on funding round data.
Can I buy Optolane stock?
Optolane shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Optolane's last funding round?
Optolane's most recent funding round was Series D Extension on November 1, 2024.
Who are the main investors in Optolane?
Key investors in Optolane include DA Value Investment, BNH INVESTMENT, UTC Investment, Timefolio Asset Management, Wonik Investment Partners.
Will Optolane IPO soon?
No public IPO plans have been announced for Optolane.
How can I track Optolane secondary market activity?
Caplight tracks bids, offers, and trades in Optolane's shares on secondary markets.